WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

As folks travel to see loved ones for the holiday season, there’s one thing no one wants to pack — an infectious disease. But whether you have the sniffles or just want to take precautions around ...

NEW YORK – UK-based molecular testing startup YouSeq last week launched 300 new qPCR tests for infectious disease pathogens, bringing its total test offering to more than 900 assays en route to its ...

As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...

The federal government program that mailed free at-home COVID-19 tests to households is no longer active. Some insurance providers may still cover the cost of at-home tests, and free tests may be ...

As summer comes to an end, COVID-19 cases are on the rise again in California. While respiratory viruses usually peak in the winter, the novel coronavirus can also surge in the warmer months.

New COVID-19 variant XFG has firmly positioned itself as the predominant strain in the United States as cases continue to crop up nationwide. Some regions of the U.S. are experiencing higher rates of ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

Several new studies have identified biomarkers of COVID-19 and long COVID, which can tell us more about what causes the diseases. These findings can also help find ways to diagnose and treat long ...